Hemodialysis is now the most common procedure under the Ayushman Bharat scheme, representing 14.1% of all treatments. With private hospitals claiming 67% of the ₹1.78 lakh crore total payout, the data highlights both a rising demand for chronic care and a shift toward state-managed trust models for healthcare delivery.
Hemodialysis has officially become the most frequent medical procedure under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), according to the National Health Authority’s 2025–26 Annual Report. This treatment accounts for 14.1% of all procedures since the scheme began, signaling a high prevalence of chronic kidney disease among beneficiaries across India. The high volume of these procedures reflects the government’s focus on providing long-term care for critical, recurring health conditions.
Treatment Mix and Hospital Participation
Beyond hemodialysis, the scheme heavily supports care for chronic and acute conditions. Multiple-package treatments make up 8.4% of total procedures, while cataract treatments follow at 6.3%. Other common interventions include management for acute febrile illness, animal bites, and gastroenteritis. Maternal healthcare also remains a central pillar, with caesarean and normal deliveries contributing significantly to the overall volume of claims.
As of March 31, 2026, the scheme has empowered 35,908 empanelled hospitals to provide care for 11.93 crore total admissions. While public and private facilities share the patient load almost equally—with private hospitals handling 52% of admissions—there is a notable difference in financial claim distribution. Private hospitals received 67% of the total claim payouts, amounting to ₹1.78 lakh crore, likely reflecting the higher cost structures associated with advanced procedures like hemodialysis and cardiac care compared to standard public hospital treatments.
Shift Toward Trust-Based Management
There is a clear administrative trend toward the Trust model for implementing AB-PMJAY. Under this structure, state governments take direct responsibility for managing finances and bearing risk, moving away from traditional insurance-based models. As of March 31, 2025, 27 states and Union Territories have adopted this approach, while only five continue with the insurance model and three utilize a hybrid strategy. This shift is designed to give states more flexibility in controlling healthcare delivery and managing claim settlements more directly.
The increasing dominance of chronic care procedures like hemodialysis indicates a long-term demand for diagnostic and dialysis infrastructure. Investors and stakeholders in the healthcare sector may track how this demand influences capital spending in dialysis centers and the expansion of private diagnostic networks. The next important monitorable will be the continued adoption of the Trust model by remaining states and any policy changes affecting the reimbursement rates for high-volume procedures, which will directly impact the financial health of empanelled hospital chains.